Who is this study for: Patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Status: Recruiting
Start Date: June 20, 2022
Intervention Type: Drug, Radiation, Other, Procedure
Study Drugs: Fludarabine
Phase: Phase 2